The Effect of Abdominal Aortic Aneurysm Screening on Mortality in Asian Population
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01205945|
Recruitment Status : Unknown
Verified September 2010 by Kyunghee University Medical Center.
Recruitment status was: Recruiting
First Posted : September 21, 2010
Last Update Posted : September 21, 2010
Abdominal aortic aneurysm(AAA) occurs when the infrarenal aorta expands to a maximal diameter of 3.0cm or greater. Although AAA may asymptomatic for many years, almost one third eventually rupture if left untreated.
Several randomized trials showed that ultrasonographic screening for AAA could reduce the frequency of acute operations and AAA-related mortality.
However, all of randomized trials were performed in Western countries. There was no randomized trials for AAA screening in Asian countries.
This randomized, controlled trial is to analyze the benefits of screening old population for AAA in Korea.
|Condition or disease|
|Aortic Aneurysm, Abdominal|
Old population, aged from 60 to 85 years, are randomized into two groups; one group is invited for ultrasonographic screening for AAA, and the other acts as age- and sex-matched controls.
For screening group, The anterioposterior and transverse diameter of the infrarenal aorta is measured at their maximal sizes. The subsequent surveillance of screened patients is done as follows
- Aortic diameter less than 3.0cm, no further testing
- AAA 3 to 4cm, ultrasonographic follow-up every year
- AAA 4 to 5cm, ultrasonographic follow-up every 6 months
- AAA greater than 5cm, referral to a vascular surgeon
For control group, the information for any causes of death is collected every year.
|Study Type :||Observational|
|Estimated Enrollment :||12000 participants|
|Official Title:||The Effect of Abdominal Aortic Aneurysm Screening on Mortality in Asian: A Randomized, Controlled Trial|
|Study Start Date :||August 2010|
|Estimated Primary Completion Date :||August 2012|
|Estimated Study Completion Date :||August 2017|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01205945
|Contact: Jin Hyun Joh, MD, PhDfirstname.lastname@example.org|
|Korea, Republic of|
|Vascular Surgery, Kyung Hee University East-West Neo Medical Center||Recruiting|
|Seoul, Korea, Republic of, 132-727|
|Contact: Jin Hyun Joh, MD, PhD 82-2-440-6261 email@example.com|
|Principal Investigator:||Jin Hyun Joh, MD, PhD||East West Neo Medical Center|